News

Intellect’s new approach specifically targets neoepitopes that are formed following cleavage of intact tau protein by executioner caspases. The pathological process is stimulated by an accumulation of amyloid

Pertuzumab, a HER2 dimerization inhibitor is designed specifically to prevent the HER2 receptor from with other HER receptors, thereby inhibiting the growth and formation of tumor. The proposed

The CryoStem has acquired adipose tissue samples utilizing a mini-liposuction procedure. A total of sixty milliliters (approximately 2 fluid ounces) of adipose tissue was collected in the physician’s

OncoCEE-BR detects CTCs, which are rare, and determines the patient’s HER2 status by fluorescence in situ hybridization (FISH). The companies will market and sell the OncoCEE-BR CTC test

The MDA grant will be used to evaluate the effect of the pharmacological chaperone AT2220 on immunogenicity related to the ERT alglucosidase alfa, the approved treatment for Pompe

Enobia develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders. Goldman, Sachs & Co. acted as financial advisor to Alexion. Ropes and Gray LLP acted

The financial details of the agreement have not been disclosed. The product is based on the Gibson Assembly method. Gibson Assembly uses a one-step, isothermal approach to enable

Prismic has also secured Scarista’s exclusive license from Amarin Neuroscience to develop, market, and out-license patents covering highly purified forms of omega-3 fatty acids for the treatment of

Based on this review classification, the FDA has issued an action date for the NDA of 5 June 2012 under the Prescription Drug User Fee Act (PDUFA). Salix